People who take aspirin may be less likely to develop melanoma, according to a study in the journal Cancer. The study included nearly 60,000 women who were light-skinned (and so at high risk for melanoma), and the researchers found that melanoma rates were 30% lower among those who reported taking full-strength aspirin regularly for five years or more. However, the researchers caution that while their study shows a correlation between taking aspirin and melanoma rates, it can’t prove that one caused the other. That said, they recommend aspirin for people who are at the highest risk for melanoma. Other studies have suggested that aspirin may lower the risk of many other cancers, including those of the bladder, breast, colon, esophagus, ovary, prostate and stomach.
Research article: http://onlinelibrary.wiley.com/doi/10.1002/cncr.27817/abstract